Interventional Strategies for Parkinson Disease: Can Neural Precursor Cells Forge a Path Ahead?
Swapna Nandakumar1, Pradnya Shahani2, Indrani Datta2
1Eyestem Research, Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru 560065, Karnataka, India.
ACS Chemical Neuroscience
|October 11, 2021
Summary
Generating mature neural subtypes from neural precursor cells (NPCs) for cell therapy is challenging. Neural stem cells (NSCs) show therapeutic potential, especially with small-molecule mediated generation and intranasal delivery for Parkinson's disease models.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Regenerative Medicine
Background:
- Neural precursor cells (NPCs) derived from pluripotent stem cells (PSCs) are valuable for studying neurological diseases.
- Generating mature neuronal subtypes from NPCs for cell therapy remains a significant challenge.
- Neural stem cells (NSCs) offer therapeutic potential due to their differentiation capacity, trophic factor release, and immunomodulatory effects.
Purpose of the Study:
- To explore strategies for generating specific neuronal subtypes from NPCs for cell therapy.
- To investigate the therapeutic potential of neural stem cells (NSCs), particularly in the context of neurological disorders.
- To examine the efficacy of small-molecule mediated NPC generation and intranasal delivery for Parkinson's disease models.
Main Methods:
- Utilizing small-molecule mediated generation of NPCs from PSCs.
- Investigating developmental cues like Wnt signaling, FGF, and retinoic acid in vitro.
- Employing intranasal delivery of PSC-derived NPCs in MPTP-induced Parkinson's disease rat models.
Main Results:
- Small-molecule mediated NPC generation from PSCs offers a consistent and robust strategy.
- Preliminary studies explored the role of PSC-derived NPCs in a rat model of Parkinson's disease.
- Intranasal delivery was investigated as a potential mode of administration for cell replacement therapy.
Conclusions:
- Advancements in understanding developmental cues and epigenetic data enhance in vitro manipulation of neural differentiation.
- The therapeutic efficacy of NPCs, influenced by their derivation strategy and delivery method, requires further investigation.
- PSC-derived NPCs delivered via intranasal injection show promise for treating neurodegenerative disorders like Parkinson's disease.
Keywords:
Parkinson diseasecell transplantationinduced pluripotent stem cellsneural precursor cellneural stem cellMore Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.0K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.0K
01:24Parkinson's Disease: Treatment
444
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
444
01:15Parkinson's Disease: Overview
845
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
845